Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
B dot Medical Successfully Develops Compact Scanning Magnet for Proton Cancer Therapy System 2021-09-09 15:00
Gan & Lee Pharmaceuticals to present data at the 57th Annual European Association for the Study of Diabetes Meeting 2021-09-09 15:00
Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility 2021-09-09 11:40
WCLC 2021 | Mini Oral - Ascentage Pharma Announces Latest Data of Its Investigational Bcl-2/Bcl-xL Inhibitor Pelcitoclax (APG-1252) Combined with Osimertinib in Patients with EGFR TKI-Resistant Non-Small Cell Lung Cancer 2021-09-09 08:26
CStone presents registrational bridging study data for GAVRETO® (pralsetinib) highlighting efficacy and safety in Chinese patients with advanced RET fusion-positive non-small cell lung cancer at IASLC WCLC 2021 2021-09-09 08:00
HaemaLogiX raises $10 million to advance multiple myeloma treatments 2021-09-09 05:00
Kintor Pharma Announces the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Androgenetic Alopecia Was Met 2021-09-08 22:13
Huadong Medicine and Insilico Medicine enter co-development partnership to advance oncology drug discovery by hitting undruggable targets 2021-09-08 20:08
The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare 2021-09-08 19:00
Yiling Pharmaceutical's Yishen Yangxin Anshen Tablets Granted Drug Certificate 2021-09-08 12:28
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors 2021-09-08 11:04
Innovent Announces First Patient with Type 2 Diabetes Dosed in a Phase 2 Clinical Trial of IBI362 (a GLP-1R and Glucagon Receptor Dual Agonist) in China 2021-09-08 08:00
Brii Biosciences Adds US$100 Million to Advance its Late-Stage Monoclonal Antibody Combination Therapy, BRII-196/BRII-198, for Non-Hospitalized COVID-19 Patients 2021-09-07 19:04
RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis 2021-09-07 19:00
RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021 2021-09-07 18:00
Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer 2021-09-07 16:11
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China 2021-09-06 19:03
GenScript ProBio Enters into Agreement with SYNIMMUNE for Manufacturing of their Innovative Antibody Drug 2021-09-06 16:00
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant 2021-09-06 13:44
Kintor Pharma Included in Hong Kong Stock Connect Program 2021-09-06 11:30
1 224 225 226 227 228 413